BioSyent Inc. - Net Worth and Insider Trading
BioSyent Inc. Net Worth
The estimated net worth of BioSyent Inc. is at least $2 Million dollars as of 2025-07-25. BioSyent Inc. is the Issuer of Biosyent Inc and owns about 205,472 shares of Biosyent Inc (TSXV:RX) stock worth over $2 Million. Details can be seen in BioSyent Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that BioSyent Inc. has not made any transactions after 2024-05-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of BioSyent Inc.
BioSyent Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, BioSyent Inc. owns 1 companies in total, including Biosyent Inc (TSXV:RX) .
Click here to see the complete history of BioSyent Inc.’s form 4 insider trades.
Insider Ownership Summary of BioSyent Inc.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| TSXV:RX | Biosyent Inc | 2024-05-22 | Issuer |
BioSyent Inc. Latest Holdings Summary
BioSyent Inc. currently owns a total of 1 stock. BioSyent Inc. owns 205,472 shares of Biosyent Inc (TSXV:RX) as of May 22, 2024, with a value of $2 Million.
Latest Holdings of BioSyent Inc.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSXV:RX | Biosyent Inc | 2024-05-22 | 205,472 | 11.44 | 2,350,600 |
Holding Weightings of BioSyent Inc.
BioSyent Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, BioSyent Inc. has made a total of 5 transactions in Biosyent Inc (TSXV:RX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Biosyent Inc is the acquisition of 1,000 shares on May 22, 2024, which cost BioSyent Inc. around $8,645.
Insider Trading History of BioSyent Inc.
- 1
BioSyent Inc. Trading Performance
GuruFocus tracks the stock performance after each of BioSyent Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by BioSyent Inc. is 2.86%. GuruFocus also compares BioSyent Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by BioSyent Inc. within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how BioSyent Inc.'s insider trading performs compared to the benchmark.
Performance of BioSyent Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.36 | | | | | |
| Relative Return to S&P 500(%) | -0.51 | | | | | |
BioSyent Inc. Ownership Network
Ownership Network List of BioSyent Inc.
Ownership Network Relation of BioSyent Inc.
BioSyent Inc. Owned Company Details
What does Biosyent Inc do?
Who are the key executives at Biosyent Inc?
BioSyent Inc. is the Issuer of Biosyent Inc. Other key executives at Biosyent Inc include 10% Security Holder Blair Driscoll , 10% Security Holder Merrilyn Joy Driscoll , and 10% Security Holder Sean Driscoll .
Biosyent Inc (TSXV:RX) Insider Trades Summary
Over the past 18 months, BioSyent Inc. made 3 insider transaction in Biosyent Inc (TSXV:RX) with a net purchase of 10,800. Other recent insider transactions involving Biosyent Inc (TSXV:RX) include a net sale of 3,075 shares made by Peter Douglas Lockhard , a net sale of 6,255 shares made by Seyed Ahmad Ashrafi , and a net sale of 375,400 shares made by FAX Capital Corp. .
In summary, during the past 3 months, insiders sold 563 shares of Biosyent Inc (TSXV:RX) in total and bought 0 shares, with a net sale of 563 shares. During the past 18 months, 2,279,829 shares of Biosyent Inc (TSXV:RX) were sold and 10,800 shares were bought by its insiders, resulting in a net sale of 2,269,029 shares.
Biosyent Inc (TSXV:RX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biosyent Inc Insider Transactions
BioSyent Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for BioSyent Inc.. Currently GuruFocus does not have mailing address information for BioSyent Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
